Atea Pharmaceuticals, Inc. financial data

Symbol
AVIR on Nasdaq
Location
225 Franklin Street, Suite 2100, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.01K % +18.1%
Debt-to-equity 7.13 % -8.12%
Return On Equity -38.4 % -10.1%
Return On Assets -35.9 % -10.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78.1M shares -7.5%
Common Stock, Shares, Outstanding 78.1M shares -7.5%
Entity Public Float 253M USD -10.8%
Common Stock, Value, Issued 78K USD -7.14%
Weighted Average Number of Shares Outstanding, Basic 79.1M shares -6.36%
Weighted Average Number of Shares Outstanding, Diluted 79.1M shares -6.36%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 126M USD -18%
General and Administrative Expense 39.1M USD -16.8%
Operating Income (Loss) -165M USD +17.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -146M USD +15.5%
Income Tax Expense (Benefit) 831K USD -20.8%
Net Income (Loss) Attributable to Parent -147M USD +15.5%
Earnings Per Share, Basic -1 USD/shares +14.1%
Earnings Per Share, Diluted -1 USD/shares +14.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 77.3M USD -21.4%
Cash, Cash Equivalents, and Short-term Investments 329M USD -31.8%
Assets, Current 336M USD -31%
Property, Plant and Equipment, Net 561K USD -42.6%
Operating Lease, Right-of-Use Asset 789K USD -43.3%
Other Assets, Noncurrent 5.48M USD +225%
Assets 343M USD -30.1%
Accounts Payable, Current 3.52M USD -39.2%
Employee-related Liabilities, Current 4.89M USD +7.78%
Liabilities, Current 20.2M USD -19.9%
Accrued Income Taxes, Noncurrent 6.8M USD +9.58%
Operating Lease, Liability, Noncurrent 213K USD -79.6%
Liabilities 27.2M USD -16.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 238K USD -62.9%
Retained Earnings (Accumulated Deficit) -478M USD -44.5%
Stockholders' Equity Attributable to Parent 316M USD -31.1%
Liabilities and Equity 343M USD -30.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -30.6M USD +23.3%
Net Cash Provided by (Used in) Financing Activities -347K USD -331%
Net Cash Provided by (Used in) Investing Activities 85.6M USD +50.7%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 78.1M shares -7.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 54.7M USD +220%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 77.3M USD -21.4%
Deferred Tax Assets, Valuation Allowance 117M USD +58%
Deferred Tax Assets, Gross 117M USD +58%
Operating Lease, Liability 1.05M USD -43.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -147M USD +14.8%
Lessee, Operating Lease, Liability, to be Paid 1.06M USD -43.9%
Property, Plant and Equipment, Gross 1.98M USD 0%
Operating Lease, Liability, Current 832K USD +5.32%
Lessee, Operating Lease, Liability, to be Paid, Year Two 855K USD +2.03%
Lessee, Operating Lease, Liability, to be Paid, Year One 855K USD +2.03%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19K USD -69.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 855K USD +2.03%
Deferred Tax Assets, Operating Loss Carryforwards 19.5M USD +108%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.36M USD +10.4%
Additional Paid in Capital 793M USD +0.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 30.4M USD -38.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%